Discover 1,407 paid clinical trials in Cleveland, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,407
Active & Responsive
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
for
Atopic Dermatitis (AD)
Location: Mayfield Heights OH, Canton OH, Warren MI,
Sponsor: Enveda Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07298395
Phase 2, Recruiting
Active & Responsive
NonNarcotic Pain Control in Percutaneous Needle Tenotomy of Elbow
for
Elbow Pain, Chronic Pain
Location: Avon OH, Coral Springs FL
Sponsor: The Cleveland Clinic
Sex: All
Age: 18 - 65
Code: NCT06373978
Recruiting
Active & Responsive
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
for
Major Depressive Disorder
Location: Avon Lake OH, Toronto, Gaithersburg MD, New York NY,
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18+
Code: NCT06966401
Phase 3, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
for
Crohn's Disease
Location: Mentor OH, Clinton Township MI, London, Ann Arbor MI,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 16 - 70+
Code: NCT06430801
Phase 3, Recruiting
Active & Responsive
Study of DONQ52 in Active Celiac Disease
for
Celiac Disease
Location: Mentor OH, Akron OH, Harrisburg PA, Lynchburg VA,
Sponsor: Chugai Pharmaceutical
Sex: All
Age: 18 - 70+
Code: NCT07239336
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Caris Biorepository Research Protocol
for
Cancer, Early Detection of Cancer, Minimal Residual Disease
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease